序号 | 英文主题词 | 中文主题词 | 命中文献数量(篇) |
---|
期刊 | 博硕士论文 | 会议论文 | 报纸 | 年鉴 | 成果 | 专利 | 国家标准 | 行业标准 | 标准 | 总计 |
3381 | Primary Care Nursing | 初级护理 | 44 | 0 | 3 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 49 |
3382 | Protease Nexins | 蛋白酶连结素 | 297 | 53 | 45 | 4 | 0 | 3 | 0 | 0 | 0 | 0 | 402 |
3383 | Protein Refolding | 蛋白质重折叠 | 39 | 14 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 58 |
3384 | Protein Unfolding | 蛋白质解折叠 | 275 | 9 | 31 | 26 | 0 | 0 | 1 | 0 | 0 | 0 | 342 |
3385 | Proton-Coupled Folate Transporter | 质子偶联叶酸转运蛋白 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
3386 | Pulp Capping and Pulpectomy Agents | 盖髓及牙髓摘除剂 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
3387 | Purinergic Agents | 嘌呤能剂 | 42 | 3 | 2 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 50 |
3388 | Purinergic Agonists | 嘌呤能激动剂 | 31 | 2 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 35 |
3389 | Purinergic Antagonists | 嘌呤能拮抗剂 | 13 | 1 | 1 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 17 |
3390 | Purinergic P1 Receptor Agonists | 嘌呤能P1受体激动剂 | 31 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 34 |
3391 | Purinergic P1 Receptor Antagonists | 嘌呤能P1受体拮抗剂 | 13 | 1 | 1 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 17 |
3392 | Purinergic P2 Receptor Agonists | 嘌呤能P2受体激动剂 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
3393 | Purinergic P2 Receptor Antagonists | 嘌呤能P2受体拮抗剂 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
3394 | Purinergic P2X Receptor Agonists | 嘌呤能P2X受体激动剂 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
3395 | Purinergic P2X Receptor Antagonists | 嘌呤能P2X受体拮抗剂 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
3396 | Purinergic P2Y Receptor Agonists | 嘌呤能P2Y受体激动剂 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
3397 | Purinergic P2Y Receptor Antagonists | 嘌呤能P2Y受体拮抗剂 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
3398 | Pycnodysostosis | 致密性成骨不全症 | 6 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 |
3399 | Pyelectasis | 肾盂扩张 | 193 | 1 | 22 | 2 | 0 | 2 | 0 | 0 | 0 | 0 | 220 |
3400 | Pyrimidine Phosphorylases | 嘧啶磷酸化酶 | 218 | 57 | 22 | 1 | 0 | 3 | 2 | 0 | 0 | 0 | 303 |